Home » Newsletters » BioWorld Science

BioWorld Science

June 5, 2014

View Archived Issues

Investigators identify biomarker for patients with Sjogren's syndrome

Clinical trial data presented for benralizumab as a treatment for asthma, COPD

Mouse papillomavirus model developed for testing antiviral responses

Novel anticancer agents divulged by Suzhou NeuPharma

Fixed-dose combinations of tiotropium and olodaterol compared to current monotherapies

Spanish scientists patent novel Dnmt1 inhibitors for cancer

GlaxoSmithKline patent describes novel DGAT1 inhibitors for obesity

Merck & Co. discloses novel prodrugs of SYK inhibitors

U.S. researchers divulge new coagulation factor XIa modulators

Bayer to codevelop Orion's ODM-201 for prostate cancer

Horizon Discovery acquires CombinatoRx service business and assets from Zalicus

ReGenX Biosciences and Voyager Therapeutics form NAV vector license agreement

Ipca and Oncobiologics form biosimilars partnership

TechnoVax receives NIH grant to develop RSV vaccine

Extended funding supports SomaLogic's development of TB diagnostic

Myriad Genetics and cancer researchers establish PROMPT genetic registry

Theravance and Theravance Biopharma separate to form two independent companies

First-in-human phase I study of RO-5520985 for advanced solid tumors

Prosensa provides regulatory update for drisapersen for DMD

Teva Pharmaceutical to acquire Labrys Biologics

Aastrom Biosciences' acquisition of Sanofi's CTRM unit complete

Asana BioSciences acquires Endo's early-stage drug discovery portfolio

Merck KGaA collaborates with Sysmex Inostics on blood-based RAS biomarker test

ASP-2215, a dual receptor tyrosine kinase inhibitor for the treatment of leukemia

EMA grants accelerated assessment to nintedanib MAA for IPF

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...